Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Sales | 44,695 | 36,774 | 78,672 | 49,930 | 273,753 |
| Cost of Goods | 25,591 | 22,296 | 20,704 | 23,378 | 107,656 |
| Gross Profit | 19,104 | 14,478 | 57,968 | 26,552 | 166,097 |
| Operating Expenses | 29,621 | 32,902 | 27,845 | 25,780 | 90,246 |
| Operating Income | -9,926 | -18,128 | 30,827 | 1,150 | 76,507 |
| Interest Expense | 335 | 971 | 1,712 | 1,764 | 7,162 |
| Other Income | 23,490 | 719 | 1,017 | 1,642 | 4,652 |
| Pre-tax Income | 13,229 | -18,380 | 30,132 | 1,028 | 73,997 |
| Income Tax | 4,307 | -7,850 | 13,044 | 568 | -51,351 |
| Net Income Continuous | 8,922 | -10,530 | 17,088 | 460 | 125,348 |
| Minority Interests | N/A | N/A | N/A | N/A | -62 |
| Net Income | $8,969 | $-10,530 | $17,088 | $460 | $125,410 |
| EPS Basic Total Ops | 0.15 | -0.18 | 0.29 | 0.01 | 2.13 |
| EPS Basic Continuous Ops | 0.15 | -0.18 | 0.29 | 0.01 | 2.13 |
| EPS Diluted Total Ops | 0.15 | -0.18 | 0.28 | 0.01 | 2.05 |
| EPS Diluted Continuous Ops | 0.15 | -0.18 | 0.28 | 0.01 | 2.05 |
| EBITDA(a) | $1,606 | $-7,130 | $43,336 | $15,879 | $144,430 |